Wenke Han

528 total citations
24 papers, 381 citations indexed

About

Wenke Han is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Wenke Han has authored 24 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Urology. Recurrent topics in Wenke Han's work include Bladder and Urothelial Cancer Treatments (8 papers), Urinary Bladder and Prostate Research (6 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Wenke Han is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Urinary Bladder and Prostate Research (6 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Wenke Han collaborates with scholars based in China, United States and Romania. Wenke Han's co-authors include Qun He, Liqun Zhou, Jie Jin, Yun Cui, Shuai Hu, Yu Fan, Wei Yu, Jicheng Lv, Libo Liu and Jie Ding and has published in prestigious journals such as PLoS ONE, Scientific Reports and Medicine.

In The Last Decade

Wenke Han

24 papers receiving 376 citations

Peers

Wenke Han
W. A. See United States
Shuai Fu China
Lukas Unger Austria
Jie Cai China
Robin Schmitz United States
Sascha Weiß Germany
Daniel Couriel United States
W. A. See United States
Wenke Han
Citations per year, relative to Wenke Han Wenke Han (= 1×) peers W. A. See

Countries citing papers authored by Wenke Han

Since Specialization
Citations

This map shows the geographic impact of Wenke Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenke Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenke Han more than expected).

Fields of papers citing papers by Wenke Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenke Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenke Han. The network helps show where Wenke Han may publish in the future.

Co-authorship network of co-authors of Wenke Han

This figure shows the co-authorship network connecting the top 25 collaborators of Wenke Han. A scholar is included among the top collaborators of Wenke Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenke Han. Wenke Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sheng, Jindong, Shuai Hu, Yun Cui, et al.. (2022). Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis. Cell Death and Disease. 13(6). 533–533. 33 indexed citations
3.
Wang, Zi, Xue Zhang, Wenke Han, et al.. (2020). Immune characteristics of renal allograft donors with mesangial IgA deposition. International Immunopharmacology. 91. 107282–107282. 9 indexed citations
4.
Zhang, Zhongyuan, Yu Fan, Cheng Shen, et al.. (2019). DDD score for renal tumor: An intuitive and comprehensive anatomical scoring system to access the outcomes of retroperitoneal laparoscopic partial nephrectomy. International Journal of Urology. 26(4). 451–456. 6 indexed citations
5.
Liu, Zhenhua, Haifeng Wang, Lian Zhang, et al.. (2019). Metabolic syndrome is associated with improved cancer-specific survival in patients with localized clear cell renal cell carcinoma. Translational Andrology and Urology. 8(5). 507–518. 8 indexed citations
6.
Liu, Jie, Yang Yang, Jindong Sheng, et al.. (2019). Activation of cGMP/PKG/p65 signaling associated with PDE5‐Is downregulates CCL5 secretion by CD8+ T cells in benign prostatic hyperplasia. The Prostate. 79(8). 909–919. 13 indexed citations
7.
Sheng, Jindong, Yun Cui, Shiming He, et al.. (2018). M2 macrophage-mediated interleukin-4 signalling induces myofibroblast phenotype during the progression of benign prostatic hyperplasia. Cell Death and Disease. 9(7). 755–755. 38 indexed citations
8.
Weng, Hongbo, Wenke Han, Yanwen Xiong, et al.. (2018). Taxus chinensis ameliorates diabetic nephropathy through down-regulating TGF- β 1/Smad pathway. Chinese Journal of Natural Medicines. 16(2). 90–96. 17 indexed citations
10.
Hu, Shuai, Jie Liu, Yun Cui, et al.. (2017). CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway. Scientific Reports. 7(1). 42893–42893. 20 indexed citations
11.
Zhang, Bo, Wei Yu, Zheng Zhao, et al.. (2017). Prognostic significance of PD-L1 expression on tumor cells and tumor-infiltrating mononuclear cells in upper tract urothelial carcinoma. Medical Oncology. 34(5). 94–94. 39 indexed citations
12.
Han, Wenke, et al.. (2017). The impact of human leukocyte antigen mismatching on graft survival and mortality in adult renal transplantation. Medicine. 96(49). e8899–e8899. 3 indexed citations
13.
Liu, Rui, Xinfang Xie, Jicheng Lv, et al.. (2017). Effect of human leukocyte antigen mismatching on the outcomes of pediatric kidney transplantation: a systematic review and meta-analysis. Nephrology Dialysis Transplantation. 32(11). 1939–1948. 5 indexed citations
14.
Zhang, Bo, Cheng Shen, Jie Jin, et al.. (2016). Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma. International Urology and Nephrology. 48(12). 1993–1999. 6 indexed citations
15.
Zhang, Bo, Yi Song, Jie Jin, et al.. (2016). Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma. PLoS ONE. 11(3). e0150193–e0150193. 12 indexed citations
16.
Zhang, Lian, Qian Zhang, Lili Li, et al.. (2015). DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer. Journal of Molecular Medicine. 93(6). 691–701. 22 indexed citations
17.
Zhang, Bo, Wei Yu, Liqun Zhou, et al.. (2015). Prognostic Significance of Preoperative Albumin-Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma. PLoS ONE. 10(12). e0144961–e0144961. 40 indexed citations
18.
Fang, Dong, Lei Zhang, Xuesong Li, et al.. (2014). Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center. Journal of Cancer Research and Clinical Oncology. 140(3). 477–485. 25 indexed citations
19.
Han, Wenke, et al.. (2014). Dual characteristic of trace rare earth elements in a commercial casting Al–Cu–X alloy. Rare Metals. 34(5). 308–313. 18 indexed citations
20.
Lin, Jian, Xiaoping Zhang, Sen Li, et al.. (2013). [Retrospective analysis of primary renal sarcoma: 17 cases report].. PubMed. 45(4). 554–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026